Appropriate approach to a patient alert in a patient undergoing biventricular implantable cardioverter defibrillator battery

@inproceedings{Aksu2017AppropriateAT,
  title={Appropriate approach to a patient alert in a patient undergoing biventricular implantable cardioverter defibrillator battery},
  author={Tolga Aksu and Tumer Erdem Guler and Sedar Bozyel},
  year={2017}
}
We reported a 46-year-old man presenting to our outpatient department because of audible alerts by his biventricular implantable cardioverter-defibrillator due to high lead and shock impedances. High impedance was associated with fluid and blood accumulation in the pacemaker header. Immediately after the pacemaker pocket was opened and drained the fluid lead and shock impedances were normalized. Correspondence to: Tolga Aksu, MD, Associate Professor of Cardiology, FESC, Kocaeli, Turkey, Zip… Expand

References

SHOWING 1-3 OF 3 REFERENCES
Annual Rate of Transvenous Defibrillation Lead Defects in Implantable Cardioverter-Defibrillators Over a Period of >10 Years
TLDR
An increasing annual lead failure rate is noted primarily during long-term follow-up and reached 20% in 10-year-old leads during the present study. Expand
Inappropriate therapy and fatal proarrhythmia by an implantable cardioverter-defibrillator.
SESSION 31: CLINICAL ELECTROPHYSIOLOGY/PHARMACOLOGY IV: Clinical EP of Ventricular Arrhythmias Friday, May 6, 2005 8:15 a.m.–9:45 a.m.
2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
Sana M. Al-Khatib, MD, MHS, FACC, FAHA, FHRS, Chair, Writing Committee, William G. Stevenson, MD, FACC, FAHA, FHRS, Vice Chair, Writing Committee, Michael J. Ackerman, MD, PhD, Writing CommitteeExpand